Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Japanese Journal of Clinical Oncology|July 20, 2016
Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancerMasaki Shiota, Akira Yokomizo, Ario Takeuchi, et al.
The Journal of Urology|December 20, 2011
Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancerMasaki Shiota, Yoohyun Song, Ario Takeuchi, et al.
Anticancer Research|October 7, 2017
Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate CancerHirofumi Obata, Masaki Shiota, Naoko Akitake, et al.
Cancer Research|June 4, 2009
Donor CD4 T cells are critical in allogeneic stem cell transplantation against murine solid tumorYoriyuki Kamiryo, Masatoshi Eto, Hisakata Yamada, et al.
The Prostate|June 19, 2013
Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptorMasaki Shiota, Eiji Kashiwagi, Akira Yokomizo, et al.
Urologic Oncology|July 27, 2020
Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapyMasaki Shiota, Satoshi Endo, Naohiro Fujimoto, et al.
Journal of Molecular Endocrinology|March 29, 2013
Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancerMomoe Itsumi, Masaki Shiota, Akira Yokomizo, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2019
The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese menMasaki Shiota, Naohiro Fujimoto, Shigehiro Tsukahara, et al.
The Prostate|June 3, 2020
High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancerMomoe Itsumi, Masaki Shiota, Yohei Sekino, et al.
Cancer Science|November 29, 2008
Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide-using non-myeloablative allogeneic hematopoietic cell transplantationMasumitsu Hamaguchi, Masatoshi Eto, Yoriyuki Kamiryo, et al.
Pageof 12